However, those patients in which the tumor had high SOX2 expression and MGMT was methylated showed a longer survival than when unmethylated with high SOX2 expression, or patients with low expression of SOX2 regardless of MGMT methylation status (Fig. 10). This evidence concerns the gene MGMT and neoplasm.